These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 24616382)
1. Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches. Silsirivanit A; Sawanyawisuth K; Riggins GJ; Wongkham C J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):388-96. PubMed ID: 24616382 [TBL] [Abstract][Full Text] [Related]
2. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma. Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055 [TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma. Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip. Park JM; Kim MJ; Noh JY; Yun TG; Kang MJ; Lee SG; Yoo BC; Pyun JC J Am Soc Mass Spectrom; 2020 Apr; 31(4):917-926. PubMed ID: 32154716 [TBL] [Abstract][Full Text] [Related]
5. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451 [TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699 [TBL] [Abstract][Full Text] [Related]
7. Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma. Wang X; Dai S; Zhang Z; Liu L; Wang J; Xiao X; He D; Liu B Eur J Cancer Care (Engl); 2009 Nov; 18(6):625-35. PubMed ID: 19486127 [TBL] [Abstract][Full Text] [Related]
8. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma. Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322 [TBL] [Abstract][Full Text] [Related]
10. A novel serum carbohydrate marker on mucin 5AC: values for diagnostic and prognostic indicators for cholangiocarcinoma. Silsirivanit A; Araki N; Wongkham C; Pairojkul C; Narimatsu Y; Kuwahara K; Narimatsu H; Wongkham S; Sakaguchi N Cancer; 2011 Aug; 117(15):3393-403. PubMed ID: 21287531 [TBL] [Abstract][Full Text] [Related]
11. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma. Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505 [TBL] [Abstract][Full Text] [Related]
12. Banking on the future: biobanking for "omics" approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand. Mulvenna J; Yonglitthipagon P; Sripa B; Brindley PJ; Loukas A; Bethony JM Parasitol Int; 2012 Mar; 61(1):173-7. PubMed ID: 21855650 [TBL] [Abstract][Full Text] [Related]
13. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A Molecules; 2021 May; 26(9):. PubMed ID: 34066878 [TBL] [Abstract][Full Text] [Related]
14. Possible involvement of cyclophilin A processing in fumagillin-induced suppression of cholangiocarcinoma cell proliferation. Sawanyawisuth K; Wongkham C; Riggins GJ; Wongkham S; Araki N Asian Pac J Cancer Prev; 2012; 13 Suppl():137-41. PubMed ID: 23480755 [TBL] [Abstract][Full Text] [Related]
15. Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. Duangkumpha K; Stoll T; Phetcharaburanin J; Yongvanit P; Thanan R; Techasen A; Namwat N; Khuntikeo N; Chamadol N; Roytrakul S; Mulvenna J; Mohamed A; Shah AK; Hill MM; Loilome W PLoS One; 2019; 14(8):e0221024. PubMed ID: 31425520 [TBL] [Abstract][Full Text] [Related]
16. Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma. Yonglitthipagon P; Pairojkul C; Bhudhisawasdi V; Mulvenna J; Loukas A; Sripa B Clin Biochem; 2012 Jul; 45(10-11):827-34. PubMed ID: 22552009 [TBL] [Abstract][Full Text] [Related]
17. Biomarker discovery for kidney diseases by mass spectrometry. Niwa T J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method. Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038 [TBL] [Abstract][Full Text] [Related]
19. Analysis of new biomarkers for cholangiocarcinoma. Miwa M; You G; Tanaka H; Taniguchi S; Fujii T; Kamemura K; Suzaki M; Isono T; Tooyama I; Tanaka M; Srivatanakul P; Viwatthanasittiphong C; Sangrajrang S; Khuhaprema T J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):397-8. PubMed ID: 24446393 [TBL] [Abstract][Full Text] [Related]
20. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis. Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]